Pay in 4 interest-free payments of $6.99 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Primary Semaglutide Injection Sites The body has several recommended areas for subcutaneous injections that will lead to stunning results
Key Takeaways Semaglutide produces clinically significant weight loss the STEP 1 trial demonstrated a mean 14.9% body weight reduction at 68 weeks with the 2.4 mg dose The dose escalation schedule is medically necessary, not optional rushing it leads to severe GI side effects that cause most treatment discontinuations Semaglutide is a long-term medication weight returns if treatment is stopped, as shown in the STEP 1 extension trial It carries real contraindications including a family history of medullary thyroid carcinoma, MEN2, pregnancy, and severe GI disease Drug interactions with oral medications are clinically relevant your full medication list must be reviewed by a pharmacist or physician before starting Maximum benefit requires combining semaglutide with a healthy diet and physical activity it reduces appetite, but it does not replace lifestyle modification References Wilding JPH, Batterham RL, Calanna S, et al
COA verified peptide bundle with syringes and supplies, shipped securely with consistent quality
Note: Ozempic is not FDA-approved for weight loss
Your healthcare provider can still write a prescription for these medications to help you lose weight, but your health insurance may not cover them for off-label use
Phase 2 data showed 24.2% weight loss at 48 weeks with no plateau, and Phase 3 TRIUMPH-4 data confirmed continued loss to 28.7% at 68 weeks
